Its not safe during pregnancy and should be stopped well in advance of trying to conceive
Although it is not specifically targeted toward belly fat, a reduction in overall body weight typically includes a decrease in abdominal fat
The SURMOUNT-5 trial showed that tirzepatide produced 20.2% body weight reduction compared to 13.7% with semaglutide over 72 weeks, a significant gap that suggests tirzepatide may push past the metabolic ceiling where semaglutide stalls
It activates AMPK (AMP-activated protein kinase), the same metabolic sensor that metformin targets, which explains the overlapping effects
As a glucagon-like peptide-1 receptor agonist (GLP-1 RA), semaglutide exerts its effects through various mechanisms within the body
According to the trials findings, semaglutide 2.4 mg once a week was considerably more effective than a placebo at helping adults with type 2 diabetes who were overweight or obese lose body weight